title: Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome.
abstract: We describe the case of a 30-year-old woman who reported several episodes of anaphylaxis with angioedema and relapsing urticaria. Some events were related to nonsteroidal anti-inflammatory drug intake and one episode followed alcohol ingestion, but in most cases no triggers could be identified. Specific immunoglobulin E determination was negative for food and drug allergens, C3 and C4 were in the normal range, C1 inhibitor was slightly reduced and serum tryptase was undetectable. In vivo autologous serum skin test and in vitro basophil histamine release assay were positive indicating the presence of circulating histamine-releasing factors. When oral tolerance tests were performed, only doxycycline was tolerated whereas levofloxacin, clarithromycin, nimesulide and tramadol caused mild urticaria. Premedication with cetirizine allowed the patient to tolerate levofloxacin, clarithromycin and nimesulide. The demonstration of circulating histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome provides a new mechanistic insight and might open the way to new therapeutic approaches.
authors.affiliation: Allergy and Clinical Immunology Unit, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Fondazione IRCCS, Milan, Italy. albited@alice.it
authors.forename: A
authors.initials: A
authors.lastname: Tedeschi
authors.forename: M
authors.initials: M
authors.lastname: Lorini
authors.forename: C
authors.initials: C
authors.lastname: Suli
authors.forename: M
authors.initials: M
authors.lastname: Cugno
mesh_terms: D000328:Adult; D000707:Anaphylaxis / Q000097:blood / Q000276:immunology*; D000900:Anti-Bacterial Agents / Q000276:immunology; D014408:Biomarkers, Tumor / Q000097:blood*; D017332:Cetirizine / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use*; D006801:Humans; D012882:Skin Tests / Q000379:methods*; D013577:Syndrome; D000090324:Tumor Protein, Translationally-Controlled 1
chemical_list: D000900:Anti-Bacterial Agents; D014408:Biomarkers, Tumor; D039563:Histamine H1 Antagonists, Non-Sedating; D000090324:Tumor Protein, Translationally-Controlled 1; D017332:Cetirizine